Consolidated Statement of Operations and Other Comprehensive Loss - USD ($) $ in Thousands |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|||||
| Income Statement [Abstract] | |||||||
| Revenue | $ 1,109,669 | $ 320,827 | $ 79,272 | ||||
| Claims expense | (1,017,003) | (219,625) | (25,120) | ||||
| Clinical care delivery expense | (80,624) | (69,831) | (42,134) | ||||
| Platform & application expenses | (29,897) | (32,723) | (32,209) | ||||
| Research & development expenses | (79,155) | (68,473) | (80,538) | ||||
| Sales, general & administrative expenses | (227,937) | (187,172) | (90,687) | ||||
| Premium deficiency reserve income / (expense) | 31,311 | (46,533) | (5,639) | ||||
| Impairment expense | (64,066) | 0 | 0 | ||||
| Depreciation and amortization expenses | (12,050) | (9,185) | (3,955) | ||||
| Loss from operations | (369,752) | (312,715) | (201,010) | ||||
| Interest expense | (32,736) | (13,047) | (4,029) | ||||
| Interest income | 1,041 | 325 | 610 | ||||
| Gain on fair value remeasurement | [1] | 192,749 | 239,195 | 0 | |||
| Loss on settlement of warrants | (2,397) | 0 | 0 | ||||
| Exchange (loss) / gain | (10,420) | 783 | (2,836) | ||||
| Gain on sale of subsidiary | 0 | 3,917 | 0 | ||||
| Share of net loss on equity method investments | 0 | (3,339) | (1,124) | ||||
| Net loss from operations before income taxes | (221,515) | (84,881) | (208,389) | ||||
| Tax benefit / (provision) | 66 | 1,443 | (4,639) | ||||
| Net loss | (221,449) | (83,438) | (213,028) | ||||
| Other comprehensive loss | |||||||
| Currency translation differences | 7,080 | (564) | 3,580 | ||||
| Other comprehensive gain / (loss), net of income tax | 7,080 | (564) | 3,580 | ||||
| Total comprehensive loss | (214,369) | (84,002) | (209,448) | ||||
| Total comprehensive loss attributable to: | |||||||
| Equity holders of the parent | (221,449) | (77,409) | (211,797) | ||||
| Non-controlling interest | 0 | (6,029) | (1,231) | ||||
| Equity including non-controlling interest | (221,449) | (83,438) | (213,028) | ||||
| Total comprehensive loss attributable to: | |||||||
| Equity holders of the parent | (214,369) | (77,973) | (208,217) | ||||
| Non-controlling interest | 0 | (6,029) | (1,231) | ||||
| Total comprehensive loss | $ (214,369) | $ (84,002) | $ (209,448) | ||||
| Net loss per share | |||||||
| Net loss per share, basic, from continuing operations (in dollars per share) | [2] | $ (12.01) | $ (6.93) | $ (21.80) | |||
| Net loss per share, diluted, from continuing operations (in dollars per share) | [2] | $ (12.01) | $ (6.93) | $ (21.80) | |||
| Weighted average shares outstanding, basic (in shares) | [2] | 18,439,104 | 11,169,203 | 9,717,434 | |||
| Weighted average shares outstanding, diluted (in shares) | [2] | 18,439,104 | 11,169,203 | 9,717,434 | |||
| |||||||
| X | ||||||||||
- Definition Clinical Care Delivery Expense No definition available.
|
| X | ||||||||||
- Definition Earnings Per Share, Basic and Diluted EPS No definition available.
|
| X | ||||||||||
- Definition Gain (Loss) On Settlement Of Derivative Liability No definition available.
|
| X | ||||||||||
- Definition Platform And Application Expenses No definition available.
|
| X | ||||||||||
- Definition Premium Deficiency Reserve Income (Expense) No definition available.
|
| X | ||||||||||
- Definition Remeasurement, Gain (Loss) On Financial Instruments No definition available.
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of other comprehensive income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|